Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
127
days
Apoptosis-driven chromosomal rearrangements in cancer: CAD cleavage, nuclear architecture, and microhomology-mediated end joining
AuthorsSang-Nee Tan
Affiliations1. Faculty of Medicine and Health Sciences, Department of Paraclinical Sciences, Universiti Malaysia Sarawak, Kota Samarahan, Malaysia
23
days
Metabolic plasticity and therapeutic opportunity in cancer
AuthorsShensi Shen
Affiliations1. Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, China
282
days
Extracellular matrix stiffness determines the phenotypic behavior of dedifferentiated melanoma cells through a DDR1/2-dependent YAP mechanotransduction pathway
AuthorsMargaux Lecacheur; Ilona Berestjuk; Alexandrine Carminati; Mira Rabbaa; Océane Bouvet; Serena Diazzi; Pierric Biber; Christopher Rovera; Marie Irondelle; Frédéric Larbret; Virginie Prod’homme; Christophe A. Girard; Marcel Deckert; Sophie Tartare-Deckert
Affiliations1. Université Côte d’Azur, INSERM, Nice, France; 2. Team “Microenvironment, Signaling and Cancer”, Equipe labellisée Ligue Contre le Cancer, Nice, France; 3. Université Côte d’Azur, INSERM, C3M, Microscopy Facility, Nice, France
211
days
Testican-1 activates Wnt/β-Catenin signaling to drive colorectal cancer progression
AuthorsYi Li; Chuying Huang; Chu Zhang; Lian Feng; Huiyun Lin; Jiannan Yao; Shu Luo; Jinsen Shi; Yuping Yang; Zhiyun Cao; Nathaniel Weygant
Affiliations1. Academy of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, China; 2. Department of Oncology, Beijing Chaoyang Hospital, Beijing, China; 3. Fujian Key Laboratory of Integrative Medicine in Geriatrics, Fujian University of Traditional Chinese Medicine, Fuzhou, China; 4. Key Laboratory of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, China
290
days
CAF-derived PTGDS drives pancreatic cancer neuroendocrine differentiation and chemoresistance via PAQR9-MAPK
AuthorsJingwen Liang; Wang Peng; Zhou Luan; Luyao Liu; Hai Huang; Haochen Cui; Mengdie Cao; Shiru Chen; Si Xiong; Shuya Bai; Wei Chen; Bin Cheng; Yuchong Zhao
Affiliations1. Department of Gastroenterology and Hepatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 2. Xiangyang Central Hospital Affiliated to Hubei University of Arts and Science, Xiangyang, China; 3. Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China; 4. Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
120
days
Anti-apoptotic BCL-2 family proteins: from regulatory networks to therapeutic targeting
AuthorsZhe Wang; Mutian Tang; Marina Konopleva
Affiliations1. Division of Immunobiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA; 2. Division of Biomedical Informatics, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA; 3. Immunology Graduate Program, University of Cincinnati, Cincinnati, USA; 4. Department of Oncology and Cell Biology, Albert Einstein College of Medicine, Bronx, USA
127
days
The emerging role of disulfidptosis in metabolic synergistic death and cancer immunotherapy
AuthorsZheng Wu; Rong Tang; Jin Xu; Yufeng Wang; Liquan Jin; Yingna Liao; Dingru Li; Cheng Zu; Chengkai Yang; Xianjun Yu; Si Shi
Affiliations1. Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China; 2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; 3. Shanghai Pancreatic Cancer Institute, Shanghai, China; 4. Shanghai Key Laboratory of Precision Medicine for Pancreatic Cancer, Shanghai, China; 5. Pancreatic Cancer Institute, Fudan University, Shanghai, China
87
days
Tipping the balance: NRF2’s dual role in ferroptotic fate
AuthorsIzadora de Souza; Ana Beatriz da Silva Teixeira; Ancely Ferreira dos Santos; José Pedro Friedmann Angeli; Clarissa Ribeiro Reily Rocha
Affiliations1. Rudolf Virchow Zentrum (RVZ), Center for Integrative and Translational Bioimaging, University of Würzburg, Würzburg, Germany; 2. Department of Clinical and Experimental Oncology, Federal University of São Paulo (UNIFESP), São Paulo, Brazil; 3. Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany
302
days
The central precocious puberty-associated gene MKRN3 is a tumor suppressor regulating CSDE1 ubiquitination in ovarian cancer
AuthorsFengrui Zhang; Chang Yuan; Yumei Cheng; Chun Chen; Luyao Guan; Xiaofang Wang; Yuxiang Luo; Chunling Zeng; Yangjie Xiong; Haoqi Lan; Yue Dong; Xiaona Jia; Simin Wang; Qi Cao; Yuexiang Wang; Yuan Lu
Affiliations1. Department of Gynecology, The Obstetrics & Gynecology Hospital of Fudan University, Shanghai, PR China; 2. CAS Key Laboratory of Tissue Microenvironment and Tumor, SINH - Changzheng Hospital Joint Center for Translational Medicine, Institutes for Translational Medicine (CAS-SMMU), Shanghai Institute of Nutrition and Health, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, PR China
118
days
Catestatin peptide impedes melanoma progression and drug resistance by reprogramming oncogenic signaling pathways
AuthorsSatadeepa Kal; Suborno Jati; Kechun Tang; Nicholas J. G. Webster; Angelo Corti; Sushil K. Mahata
Affiliations1. Veterans Medical Research Foundation, San Diego, USA; 2. Department of Medicine, University of California, San Diego, USA; 3. Department of Neurosciences, University of California, San Diego, USA; 4. VA San Diego Healthcare System, San Diego, USA; 5. IRCCS San Raffaele Scientific Institute, San Raffaele Vita-Salute University, Milan, Italy
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days